title: Response to comment on Brunnekreef et al.: Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?
authors.forename: Jaap J
authors.initials: JJ
authors.lastname: Brunnekreef
authors.forename: Berend W
authors.initials: BW
authors.lastname: Schreurs
mesh_terms: D019644:Arthroplasty, Replacement, Hip / Q000009:adverse effects*; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009999:Ossification, Heterotopic / Q000209:etiology* / Q000517:prevention & control*; D015207:Osteoarthritis, Hip / Q000601:surgery*; D011725:Pyridines / Q000627:therapeutic use*; D013450:Sulfones / Q000627:therapeutic use*
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; D011725:Pyridines; D013450:Sulfones